A prospective and multicenter trial of intravenous immunoglobulin therapy for idiopathic pulmonary fibrosis
Not Applicable
- Conditions
- Idiopathic pulmonary fibrosis
- Registration Number
- JPRN-UMIN000013559
- Lead Sponsor
- Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Coexisting or clinical suspicion of sarcoidosis, hypersensitivity pneumonitis, connective tissue diseases, pneumoconiosis, drug-induced pneumonitis, infectious disease, pregnancy, coexisting chronic obstructive pulmonary disease (COPD), bronchial asthma, bronchiectasis, neoplasm, severe cardiovascular disease, cerebrovascular disease, chronic kidney disease, or thromboembolism. Patients who were unable to undergo physiologic tests, unable to understand the protocol or provide written informed consent, or who were administered with 20 mg/day or more of predonisolone, immunosuppressive agents, antifibrotic agents, or immunoglobulin during the preceding 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method